FDA inspection
Daicel Chiral Technologies (India) Private Limited: FDA inspection ending Feb 14, 2024
FDA inspection 1229717 · Voluntary Action Indicated (VAI) · Hyderabad
Key facts
| Inspection ID | 1229717 |
|---|---|
| Firm | Daicel Chiral Technologies (India) Private Limited |
| FEI number | 3009883135 |
| Address | 2 Medchal Malkajgiri District, Survey No 542; Shamirpet Mandal |
| City | Hyderabad |
| Country | India |
| Fiscal year | 2024 |
| Inspection end date | Feb 14, 2024 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- Yes Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data